Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ketamine | 16 | 2022 | 503 | 3.890 |
Why?
|
Depressive Disorder, Major | 45 | 2022 | 4691 | 2.160 |
Why?
|
Antidepressive Agents | 24 | 2022 | 2871 | 1.710 |
Why?
|
Suicidal Ideation | 3 | 2020 | 1270 | 0.970 |
Why?
|
Riluzole | 1 | 2019 | 58 | 0.660 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2020 | 446 | 0.630 |
Why?
|
Bipolar Disorder | 24 | 2023 | 5069 | 0.570 |
Why?
|
Infusions, Intravenous | 7 | 2022 | 2220 | 0.560 |
Why?
|
Depression | 12 | 2023 | 7917 | 0.550 |
Why?
|
Tryptophan Hydroxylase | 8 | 2004 | 93 | 0.500 |
Why?
|
Polymorphism, Genetic | 19 | 2005 | 4285 | 0.490 |
Why?
|
Monoamine Oxidase | 3 | 2002 | 179 | 0.440 |
Why?
|
Receptors, Dopamine D2 | 9 | 2004 | 482 | 0.440 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1241 | 0.430 |
Why?
|
Depressive Disorder | 13 | 2019 | 3726 | 0.410 |
Why?
|
Benzothiazoles | 1 | 2013 | 247 | 0.410 |
Why?
|
Mood Disorders | 10 | 2005 | 1109 | 0.390 |
Why?
|
Electroconvulsive Therapy | 2 | 2016 | 501 | 0.390 |
Why?
|
Antidepressive Agents, Second-Generation | 6 | 2006 | 489 | 0.390 |
Why?
|
Double-Blind Method | 21 | 2022 | 12326 | 0.360 |
Why?
|
Membrane Transport Proteins | 9 | 2004 | 1036 | 0.360 |
Why?
|
Pregnanolone | 2 | 2020 | 67 | 0.340 |
Why?
|
Fluoxetine | 3 | 2007 | 736 | 0.310 |
Why?
|
Psychiatric Status Rating Scales | 15 | 2018 | 6001 | 0.310 |
Why?
|
Sertraline | 2 | 2020 | 208 | 0.290 |
Why?
|
Fluvoxamine | 7 | 2005 | 77 | 0.290 |
Why?
|
Citalopram | 3 | 2019 | 402 | 0.280 |
Why?
|
Receptor, Serotonin, 5-HT2A | 4 | 2004 | 64 | 0.280 |
Why?
|
Receptors, Serotonin | 3 | 2002 | 205 | 0.280 |
Why?
|
Psychotic Disorders | 7 | 2015 | 3138 | 0.270 |
Why?
|
Drug Administration Schedule | 4 | 2019 | 4880 | 0.270 |
Why?
|
Huntington Disease | 1 | 2013 | 1134 | 0.270 |
Why?
|
Treatment Outcome | 31 | 2022 | 64245 | 0.270 |
Why?
|
Membrane Glycoproteins | 9 | 2004 | 3668 | 0.250 |
Why?
|
Middle Aged | 65 | 2022 | 217019 | 0.240 |
Why?
|
Catechol O-Methyltransferase | 3 | 2004 | 247 | 0.240 |
Why?
|
Nerve Tissue Proteins | 10 | 2004 | 4412 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2020 | 10797 | 0.240 |
Why?
|
Drug Synergism | 4 | 2017 | 1735 | 0.230 |
Why?
|
Remission Induction | 3 | 2016 | 2367 | 0.230 |
Why?
|
Adult | 62 | 2023 | 216913 | 0.230 |
Why?
|
Deep Brain Stimulation | 3 | 2016 | 801 | 0.210 |
Why?
|
Outpatients | 3 | 2020 | 1575 | 0.210 |
Why?
|
Lithium | 2 | 2002 | 598 | 0.210 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 10 | 2006 | 323 | 0.190 |
Why?
|
Carrier Proteins | 7 | 2002 | 4932 | 0.190 |
Why?
|
Female | 71 | 2023 | 386053 | 0.190 |
Why?
|
Humans | 93 | 2023 | 752341 | 0.180 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.180 |
Why?
|
Male | 66 | 2023 | 354881 | 0.180 |
Why?
|
Yoga | 1 | 2023 | 267 | 0.170 |
Why?
|
Paroxetine | 5 | 2005 | 182 | 0.170 |
Why?
|
Time Factors | 5 | 2021 | 39854 | 0.170 |
Why?
|
Follicular Phase | 1 | 2019 | 144 | 0.170 |
Why?
|
Luteal Phase | 1 | 2019 | 139 | 0.170 |
Why?
|
Delusions | 9 | 2002 | 298 | 0.160 |
Why?
|
Tyrosine 3-Monooxygenase | 4 | 2003 | 371 | 0.160 |
Why?
|
S-Adenosylmethionine | 1 | 2019 | 212 | 0.150 |
Why?
|
Administration, Intranasal | 1 | 2020 | 472 | 0.150 |
Why?
|
Psychotropic Drugs | 1 | 2023 | 883 | 0.150 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 28 | 0.150 |
Why?
|
Irritable Mood | 2 | 2020 | 182 | 0.140 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2013 | 1960 | 0.140 |
Why?
|
Neuromuscular Depolarizing Agents | 1 | 2016 | 43 | 0.140 |
Why?
|
Androstanols | 1 | 2016 | 46 | 0.140 |
Why?
|
Succinylcholine | 1 | 2016 | 66 | 0.140 |
Why?
|
Drug Therapy, Combination | 7 | 2020 | 6482 | 0.140 |
Why?
|
Seasons | 1 | 2002 | 1514 | 0.130 |
Why?
|
Dopamine | 2 | 2022 | 1578 | 0.130 |
Why?
|
Pindolol | 4 | 2005 | 33 | 0.130 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2016 | 143 | 0.130 |
Why?
|
Young Adult | 17 | 2022 | 57629 | 0.130 |
Why?
|
Progesterone | 1 | 2019 | 751 | 0.130 |
Why?
|
Hypericum | 1 | 2014 | 58 | 0.120 |
Why?
|
Placebos | 2 | 2012 | 1665 | 0.120 |
Why?
|
Premenopause | 1 | 2019 | 1034 | 0.120 |
Why?
|
Postmenopause | 3 | 2020 | 2493 | 0.120 |
Why?
|
Naltrexone | 1 | 2016 | 307 | 0.120 |
Why?
|
Receptors, Dopamine D4 | 7 | 2004 | 168 | 0.120 |
Why?
|
Synaptic Transmission | 1 | 2020 | 1163 | 0.120 |
Why?
|
Internal Capsule | 1 | 2014 | 138 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1378 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 725 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 907 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2019 | 2613 | 0.100 |
Why?
|
Menopause | 1 | 2019 | 1638 | 0.100 |
Why?
|
Anger | 2 | 2020 | 403 | 0.100 |
Why?
|
Pilot Projects | 6 | 2022 | 8443 | 0.090 |
Why?
|
Plant Extracts | 1 | 2014 | 495 | 0.090 |
Why?
|
Injections, Intramuscular | 1 | 2012 | 554 | 0.090 |
Why?
|
Genotype | 15 | 2007 | 12869 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2018 | 5697 | 0.090 |
Why?
|
Dopamine Agonists | 1 | 2013 | 349 | 0.090 |
Why?
|
Institutionalization | 1 | 1991 | 105 | 0.090 |
Why?
|
Thiazoles | 1 | 2018 | 1505 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2652 | 0.090 |
Why?
|
Paranoid Disorders | 2 | 1999 | 61 | 0.090 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 605 | 0.080 |
Why?
|
Testosterone | 1 | 2020 | 2465 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2479 | 0.080 |
Why?
|
Midazolam | 2 | 2022 | 264 | 0.080 |
Why?
|
Antimanic Agents | 2 | 2023 | 520 | 0.080 |
Why?
|
Pattern Recognition, Automated | 1 | 2015 | 992 | 0.080 |
Why?
|
Aged | 22 | 2020 | 166562 | 0.080 |
Why?
|
Reaction Time | 1 | 2015 | 2058 | 0.080 |
Why?
|
Piperazines | 2 | 2018 | 2486 | 0.080 |
Why?
|
Universities | 1 | 2013 | 950 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8538 | 0.080 |
Why?
|
Long-Term Care | 1 | 2012 | 621 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1161 | 0.080 |
Why?
|
Genetic Variation | 6 | 2006 | 6507 | 0.070 |
Why?
|
Dementia | 1 | 2022 | 2586 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6413 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2688 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8707 | 0.070 |
Why?
|
Drug Monitoring | 1 | 2013 | 959 | 0.070 |
Why?
|
Receptors, Dopamine D3 | 3 | 2022 | 106 | 0.070 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2016 | 1482 | 0.070 |
Why?
|
Psychometrics | 1 | 2016 | 3005 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2020 | 79127 | 0.070 |
Why?
|
Executive Function | 1 | 2015 | 1350 | 0.070 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 2 | 2004 | 93 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2016 | 2708 | 0.060 |
Why?
|
Recurrence | 4 | 2019 | 8420 | 0.060 |
Why?
|
Anxiety | 2 | 2018 | 4456 | 0.060 |
Why?
|
Minisatellite Repeats | 1 | 2005 | 162 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 490 | 0.060 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2005 | 185 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8362 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2004 | 784 | 0.060 |
Why?
|
Receptors, GABA-A | 2 | 1999 | 624 | 0.060 |
Why?
|
Alleles | 11 | 2006 | 6879 | 0.060 |
Why?
|
Gene Frequency | 7 | 2005 | 3586 | 0.060 |
Why?
|
Students | 1 | 2013 | 1667 | 0.060 |
Why?
|
Cross-Over Studies | 2 | 2022 | 2032 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 499 | 0.060 |
Why?
|
Adolescent | 11 | 2020 | 86765 | 0.060 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2005 | 417 | 0.050 |
Why?
|
Euphoria | 1 | 2022 | 68 | 0.050 |
Why?
|
Serotonin Antagonists | 2 | 2018 | 144 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12796 | 0.050 |
Why?
|
Raclopride | 1 | 2022 | 101 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39079 | 0.050 |
Why?
|
Psychopathology | 2 | 2021 | 418 | 0.050 |
Why?
|
Italy | 5 | 2003 | 837 | 0.050 |
Why?
|
Schizophrenia | 5 | 2002 | 6879 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 1991 | 2400 | 0.050 |
Why?
|
Prefrontal Cortex | 2 | 2022 | 2186 | 0.050 |
Why?
|
Linkage Disequilibrium | 3 | 2005 | 1989 | 0.050 |
Why?
|
Software | 1 | 2015 | 4420 | 0.050 |
Why?
|
Systems Analysis | 1 | 2021 | 168 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3821 | 0.050 |
Why?
|
Gene Expression | 3 | 2001 | 7580 | 0.040 |
Why?
|
GABA Modulators | 1 | 2020 | 109 | 0.040 |
Why?
|
Protein Subunits | 1 | 2003 | 944 | 0.040 |
Why?
|
Haplotypes | 1 | 2005 | 2744 | 0.040 |
Why?
|
Bupropion | 1 | 2020 | 305 | 0.040 |
Why?
|
Serotonin | 2 | 2001 | 1032 | 0.040 |
Why?
|
Affective Disorders, Psychotic | 1 | 1999 | 186 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8931 | 0.040 |
Why?
|
Polymerase Chain Reaction | 6 | 2006 | 6058 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 608 | 0.040 |
Why?
|
Patient Discharge | 1 | 1991 | 3412 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2005 | 1064 | 0.040 |
Why?
|
Health Status | 1 | 1991 | 4050 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6846 | 0.040 |
Why?
|
Disease Progression | 2 | 2007 | 13402 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1998 | 410 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1120 | 0.030 |
Why?
|
Antipsychotic Agents | 2 | 2023 | 3050 | 0.030 |
Why?
|
Mental Health | 1 | 1991 | 3150 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4550 | 0.030 |
Why?
|
Age of Onset | 5 | 2002 | 3288 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 1247 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10198 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 35916 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 898 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2851 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1820 | 0.030 |
Why?
|
Severity of Illness Index | 6 | 2007 | 15676 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2387 | 0.030 |
Why?
|
Genetic Linkage | 1 | 2000 | 2385 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15130 | 0.030 |
Why?
|
Regression Analysis | 2 | 2000 | 6360 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1102 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1881 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26655 | 0.030 |
Why?
|
Erythrocytes | 1 | 2002 | 2400 | 0.030 |
Why?
|
Analysis of Variance | 4 | 2004 | 6234 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 1572 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1444 | 0.030 |
Why?
|
Schizophrenic Psychology | 1 | 1999 | 1646 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2020 | 1795 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3196 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2004 | 3463 | 0.030 |
Why?
|
Personality Inventory | 2 | 2007 | 1018 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2016 | 1199 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 7995 | 0.020 |
Why?
|
Models, Psychological | 1 | 2015 | 813 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3805 | 0.020 |
Why?
|
Psychological Tests | 2 | 2003 | 636 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2247 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2172 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3678 | 0.020 |
Why?
|
Prevalence | 1 | 2007 | 15506 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1791 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3369 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2400 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15645 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6170 | 0.020 |
Why?
|
DNA | 4 | 2004 | 7215 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21158 | 0.020 |
Why?
|
DNA Primers | 2 | 2001 | 2804 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7808 | 0.020 |
Why?
|
Prognosis | 1 | 2007 | 29327 | 0.020 |
Why?
|
CLOCK Proteins | 1 | 2005 | 85 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 25535 | 0.010 |
Why?
|
Jews | 1 | 2005 | 359 | 0.010 |
Why?
|
Wolfram Syndrome | 1 | 2003 | 15 | 0.010 |
Why?
|
Nursing Homes | 1 | 1991 | 1059 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 21841 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10690 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2003 | 342 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3647 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2015 | 6955 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2016 | 58300 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1999 | 11883 | 0.010 |
Why?
|
DNA Mutational Analysis | 2 | 2001 | 4110 | 0.010 |
Why?
|
Schizophrenia, Paranoid | 1 | 2001 | 103 | 0.010 |
Why?
|
Social Support | 1 | 1991 | 2118 | 0.010 |
Why?
|
Serotonin Receptor Agonists | 1 | 2001 | 152 | 0.010 |
Why?
|
Individuality | 1 | 2001 | 299 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9158 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 53807 | 0.010 |
Why?
|
Life Style | 1 | 1991 | 3858 | 0.010 |
Why?
|
Anomie | 1 | 1998 | 9 | 0.010 |
Why?
|
Inpatients | 2 | 2002 | 2561 | 0.010 |
Why?
|
Obesity | 1 | 2020 | 12806 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1999 | 421 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4573 | 0.010 |
Why?
|
Length of Stay | 1 | 1991 | 6372 | 0.010 |
Why?
|
Risk Factors | 2 | 2002 | 73412 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4572 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19894 | 0.010 |
Why?
|
Hallucinations | 1 | 1999 | 361 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 1999 | 984 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 1591 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 3 | 2005 | 17648 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2383 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2007 | 2743 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 2348 | 0.010 |
Why?
|
Psychomotor Agitation | 1 | 1998 | 305 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5782 | 0.010 |
Why?
|
Personality Disorders | 1 | 1999 | 716 | 0.010 |
Why?
|
Somatoform Disorders | 1 | 1998 | 420 | 0.010 |
Why?
|
Genetic Markers | 1 | 2000 | 2605 | 0.010 |
Why?
|
Europe | 1 | 2000 | 3404 | 0.010 |
Why?
|
Sex Factors | 1 | 2007 | 10455 | 0.010 |
Why?
|
Family | 1 | 2003 | 3165 | 0.010 |
Why?
|
United States | 1 | 2020 | 71442 | 0.010 |
Why?
|
Phenotype | 2 | 2000 | 16439 | 0.010 |
Why?
|
Suicide | 1 | 2002 | 1505 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12137 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1998 | 1129 | 0.010 |
Why?
|
Cluster Analysis | 1 | 1998 | 2682 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4628 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 12738 | 0.010 |
Why?
|
Base Sequence | 1 | 2000 | 12432 | 0.000 |
Why?
|
Patient Readmission | 1 | 2002 | 3288 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 4717 | 0.000 |
Why?
|
Motor Activity | 1 | 1998 | 2677 | 0.000 |
Why?
|
Age Factors | 1 | 2003 | 18297 | 0.000 |
Why?
|
Comorbidity | 1 | 1999 | 10475 | 0.000 |
Why?
|
Child, Preschool | 1 | 2005 | 41659 | 0.000 |
Why?
|
Child | 1 | 2005 | 78998 | 0.000 |
Why?
|
Cohort Studies | 1 | 1999 | 40984 | 0.000 |
Why?
|